Navigation Links
UNC research highlights at 2011 Digestive Disease Week
Date:5/9/2011

Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 7-10, at McCormick Place in Chicago, Ill. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology.

The following are a selection of oral presentations given at this year's DDW by University of North Carolina at Chapel Hill School of Medicine researchers.

1. Meditation offers relief for people with irritable bowel syndrome

This first-ever randomized controlled trial of the effect of mindfulness meditation training on irritable bowel syndrome found that the behavioral technique could significantly reduce the severity of symptoms. Dr. Olafur Palsson, associate professor of medicine, division of gastroenterology and hepatology, and UNC co-investigators also found that over time mindfulness training also reduced psychological distress associated with IBS. The study was led by Susan Gaylord, PhD, director of the University of North Carolina Program on Integrative Medicine.

2. Tough economic times affect colonoscopy screening rates even among the insured

This study sought to determine if the recent economic recession had an impact on the use of screening colonoscopy among people with health insurance. Dr. Spencer D. Dorn, assistant professor of medicine and co-investigators in the division of gastroenterology and hepatology at UNC found that it did. Colonoscopy rates decreased among insured Americans during the recession, with high out-of-pocket costs a major factor. The findings support policies aimed at reducing costs for the procedure.

3. Diets high in fiber won't protect against diverticulosis

People whose diets are low in fiber are thought to be at greater risk for developing the diverticular disease of the large intestine than those who eat high-fiber diets. The disease, in which pouches develop in the colon wall, affects about one-third of adults over age 60 and often occurs without symptoms. But complications can be severe and resultant U.S. health expenditures very high, an estimated $2.5 billion per year. A study of more than 2,000 people reported by Anne Peery, MD, fellow in the gastroenterology and hepatology division at UNC, could change dietary recommendations regarding the problem. Rather than a decrease, Peery and co-investigators found an increased risk of diverticulosis in people whose diets are high in fiber and who have more frequent bowel movements.


'/>"/>

Contact: Les Lang
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... , ... August 18, 2017 ... ... Quick International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex ... into a definitive agreement to purchase Unitrans International Corporation, a division of ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry ... educational webinar, they will present the line of epMotion automated liquid handling system. ... you can automate everyday pipetting tasks. , Ideal for scientists and lab technicians ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning services to communities in east Texas, is launching a regional charity effort ... , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly ...
(Date:8/18/2017)... ... ... The Golseth Agency, a Texas based insurance management and financial planning assistance provider ... organized to provide support to Christina Upchurch and her two children after the loss ... returned from out of town to find her husband passed away and their home ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids ... marketing efforts with its product now available through Jet.com. , After 25 years ... effervescent powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
Breaking Medicine Technology: